Three-dimensional pharmacophore modeling of liver-X receptor agonists

Journal of Chemical Information and Modeling

Volumn 51, Issue 9, 2011, Pages 2147-2155

  Zhao, Wenxia ^a   Gu, Qiong ^a   Wang, Ling ^a   Ge, Hu ^a   Li, Jiabo ^b   Xu, Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b ACCELRYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHOLESTEROL; LIGANDS;

ATTRACTIVE SOLUTIONS; BINDING BEHAVIORS; CHOLESTEROL ABSORPTION; HIGH CHOLESTEROLS; LIVER X RECEPTORS; PHARMACOPHORE MODELING; PHARMACOPHORE MODELS; VIRTUAL SCREENING;

PHARMACODYNAMICS;

LIGAND; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; DRUG POTENTIATION; HUMAN; HYPERLIPIDEMIA; VALIDATION STUDY;

HUMANS; HYPERLIPIDEMIAS; LIGANDS; MODELS, MOLECULAR; ORPHAN NUCLEAR RECEPTORS;

EID: 80053316442     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci100511v     Document Type: Article

References (32)

1. Governments Ignore the Worlds Leading Cause of Death; World Heart Federation: Geneva, Switzerland http://www.world-heart-federation.org/fileadmin/ user-upload/documents/press-releases-esc-4sept.pdf. Accessed September 4, 2005).
2. Spreafico, M.; Smiesko, M.; Peristera, O.; Rossato, G.; Vedani, A. Probing Small-Molecule Binding to the Liver-X Receptor: A Mixed-Model QSAR Study Mol. Inf. 2010, 29, 27-36
3. Yang, C. D.; McDonald, J. G.; Patel, A.; Zhang, Y.; Umetani, M.; Xu, F.; Westover, E. J.; Covey, D. F.; Mangelsdorf, D. J.; Cohen, J. C.; Hobbs, H. H. Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands J. Biol. Chem. 2006, 281, 27816-27826 (Pubitemid 44414494)
4. Whitney, K. D.; Watson, M. A.; Collins, J. L.; Benson, W. G.; Stone, T. M.; Numerick, M. J.; Tippin, T. K.; Wilson, J. G.; Winegar, D. A.; Kliewer, S. A. Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System Mol. Endocrinol. 2002, 16, 1378-1385 (Pubitemid 34621083)
5. Yang, C. D.; McDonald, J. G.; Cohen, J. C.; Hobbs, H. H. Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands FASEB J. 2007, 21, A979-A979
6. Zhao, C. Y.; Dahlman-Wright, K. Liver X Receptor in Cholesterol Metabolism J. Endocrinol. 2010, 204, 233-240
7. Janowski, B. A.; Willy, P. J.; Devi, T. R.; Falck, J. R.; Mangelsdorf, D. J. An Oxysterol Signalling Pathway Mediated by the Nuclear Receptor LXR Alpha Nature 1996, 383, 728-731 (Pubitemid 26360651)
8. Fan, X. K.; H., J.; Bouton, D.; Warner, M.; Gustafsson, J. A. Expression of Liver X Receptor Beta is Essential for Formation of Superficial Cortical Layers and Migration of Later-Born Neurons Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 13445-13450
9. Calkin, A. C.; T., P. Liver X Receptor Signaling Pathways and Atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2010, 30, 1513-1518
10. Repa, J. J.; Turley, S. D.; Lobaccaro, J. M. A.; Medina, J.; Li, L.; Lustig, K.; Shan, B.; Heyman, R. A.; Dietschy, J. M.; Mangelsdorf, D. J. Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers Science 2000, 289, 1524-1529
11. Repa, J. J.; Liang, G. S.; Ou, J. F.; Bashmakov, Y.; Lobaccaro, J. M. A.; Shimomura, I.; Shan, B.; Brown, M. S.; Goldstein, J. L.; Mangelsdorf, D. J. Regulation of Mouse Sterol Regulatory Element-Binding Protein-1c Gene (SREBP-1c) by Oxysterol Receptors, LXR Alpha and LXR Beta Genes & Dev. 2000, 14, 2819-2830
12. Wang, X.; Collins, H. L.; Ranalletta, M.; Fuki, I. V.; Billheimer, J. T.; Rothblat, G. H.; Tall, A. R.; Rader, D. J. Macrophage ABCA1 and ABCG1, But not SR-BI, Promote Macrophage Reverse Cholesterol Transport in Vivo J. Clin. Invest. 2007, 117, 2216-2224 (Pubitemid 47219566)
13. Brown, M. S.; Goldstein, J. L. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor Cell 1997, 89, 331-340 (Pubitemid 27220877)
14. Bradley, M. N.; Hong, C.; Chen, M.; Joseph, S. B.; Wilpitz, D. C.; Wang, X.; Lusis, A. J.; Collins, A.; Hseuh, W. A.; Collins, J. L.; Tangirala, R. K.; Tontonoz, P. Ligand Activation of LXR Beta Reverses Atherosclerosis and Cellular Cholesterol Overload in Mice Lacking LXR Alpha and ApoE J. Clin. Invest. 2007, 117, 2337-2346 (Pubitemid 47219578)
15. Travins, J. M.; Bernotas, R. C.; Kaufman, D. H.; Quinet, E.; Nambi, P.; Feingold, I.; Huselton, C.; Wilhelmsson, A.; Goos-Nilsson, A.; Wrobel, J. 1-(3-Aryloxyaryl) Benzimidazole Sulfones are Liver X Receptor Agonists Bioorg. Med. Chem. Lett. 2010, 20, 526-530
16. Singhaus, R. R.; Bernotas, R. C.; Steffan, R.; Matelan, E.; Quinet, E.; Nambi, P.; Feingold, I.; Huselton, C.; Wilhelmsson, A.; Goos-Nilsson, A.; Wrobel, J. 3-(3-Aryloxyaryl) Imidazo [1,2-a] Pyridine Sulfones as Liver X Receptor Agonists Bioorg. Med. Chem. Lett. 2010, 20, 521-525
17. Szewczyk, J. W.; Huang, S.; Chin, J.; Tian, J.; Mitnal, L.; Rosa, R. L.; Peterson, L.; Sparrow, C. P.; Adams, A. D. SAR Studies: Designing Potent and Selective LXR Agonists Bioorg. Med. Chem. Lett. 2006, 16, 3055-3060 (Pubitemid 44316649)
18. Bernotas, R. C.; Kaufman, D. H.; Singhaus, R. R.; Ullrich, J.; Unwalla, R.; Quinet, E.; Nambi, P.; Wilhelmsson, A.; Goos-Nilsson, A.; Wrobel, J. 4-(3-Aryloxyaryl) Quinoline Alcohols are Liver X Receptor Agonists Bioorg. Med. Chem. 2009, 17, 8086-8092
19. Ullrich, J. W.; Morris, R.; Bernotas, R. C.; Travins, J. M.; Jetter, J.; Unwalla, R.; Quinet, E.; Nambi, P.; Feingold, I.; Huselton, C.; Enroth, C.; Wilhelmsson, A.; Goos-Nilsson, A.; Wrobel, J. Synthesis of 4-(3-Biaryl) Quinoline Sulfones as Potent Liver X Receptor Agonists Bioorg. Med. Chem. Lett. 2010, 20, 2903-2907
20. Bernotas, R. C.; Singhaus, R. R.; Kaufman, D. H.; Ullrich, J.; Fletcher, H.; Quinet, E.; Nambi, P.; Unwalla, R.; Wilhelmsson, A.; Goos-Nilsson, A.; Farnegardh, M.; Wrobel, J. Biarylether Amide Quinolines as Liver X Receptor Agonists Bioorg. Med. Chem. 2009, 17, 1663-1670
21. Wrobel, J.; Steffan, R.; Bowen, S. M.; Magolda, R.; Matelan, E.; Unwalla, R.; Basso, M.; Clerin, V.; Gardell, S. J.; Nambi, P.; Quinet, E.; Reminick, J. I.; Vlasuk, G. P.; Wang, S.; Feingold, I.; Huselton, C.; Bonn, T.; Farnegardh, M.; Hansson, T.; Nilsson, A. G.; Wilhelmsson, A.; Zamaratski, E.; Evans, M. J. Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis J. Med. Chem. 2008, 51, 7161-7168
22. Li, H. F.; Lu, T.; Zhu, T.; Jiang, Y. J.; Rao, S. S.; Hu, L. Y.; Xin, B. T.; Chen, Y. D. Virtual Screening for Raf-1 Kinase Inhibitors Based on Pharmacophore Model of Substituted Ureas Eur. J. Med. Chem. 2009, 44, 1240-1249
23. Sakkiah, S.; Thangapandian, S.; John, S.; Kwon, Y. J.; Lee, K. W. 3D QSAR Pharmacophore Based Virtual Screening and Molecular Docking for Identification of Potential HSP90 Inhibitors Eur. J. Med. Chem. 2010, 45, 2132-2140
24. Sundarapandian, T.; Shalini, J.; Sugunadevi, S.; Woo, L. K. Docking-Enabled Pharmacophore Model for Histone Deacetylase 8 Inhibitors and Its Application in Anti-Cancer Drug Discovery J. Mol. Graphics Modell. 2010, 29, 382-395
25. Yankeelov, J. A., Jr.; Koshland, D. E., Jr. Evidence for Conformation Changes Induced by Substrates of Phosphoglucomutase J. Biol. Chem. 1965, 240, 1593-602
26. Kirchmair, J.; Laggner, C.; Wolber, G.; Langer, T. Comparative Analysis of Protein-Bound Ligand Conformations with Respect to Catalysts Conformational Space Subsampling Algorithms J. Chem. Inf. Model. 2005, 45, 422-30 (Pubitemid 40635351)
27. Bernotas, R. C.; Singhaus, R. R.; Kaufman, D. H.; Travins, J. M.; Ullrich, J. W.; Unwalla, R.; Quinet, E.; Evans, M.; Nambi, P.; Olland, A.; Kauppi, B.; Wilhelmsson, A.; Goos-Nilsson, A.; Wrobel, J. 4-(3-Aryloxyaryl) Quinoline Sulfones are Potent Liver X Receptor Agonists Bioorg. Med. Chem. Lett. 2010, 20, 209-212
28. Rarey, M. K., B.; Lengauer, T.; Klebe, G. A Fast Flexible Docking Method Using an Incremental Construction Algorithm J. Mol. Biol. 1996, 261, 470-489 (Pubitemid 26335901)
29. Discovery Studio, version 2.1; Accelrys Inc: San Diego, CA, 2007.
30. Kurogi, Y.; Guner, O. F. Pharmacophore Modeling and Three-Dimensional Database Searching for Drug Design Using Catalyst Curr. Med. Chem. 2001, 8, 1035-1055 (Pubitemid 32633658)
31. Aparoy, P.; Kumar Reddy, K.; Kalangi, S. K.; Chandramohan Reddy, T.; Reddanna, P. Pharmacophore Modeling and Virtual Screening for Designing Potential 5-Lipoxygenase Inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 1013-1018
32. Farnegardh, M.; Bonn, T.; Sun, S.; Ljunggren, J.; Ahola, H.; Wilhelmsson, A.; Gustafsson, J. A.; Carlquist, M. The Three-Dimensional Structure of the Liver X Receptor Beta Reveals a Flexible Ligand-Binding Pocket that Can Accommodate Fundamentally Different Ligands J. Biol. Chem. 2003, 278, 38821-38828 (Pubitemid 37229066)